Projects and Grants per year
- 150 - 200 out of 2,005 results
Search results
-
Active
22-MULTI-47-GS (IMMU-132-11): A Phase 2 Open-Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects with Metastatic Solid Tumors
Arnold, S. (PI)
7/12/22 → 4/27/25
Project: Research project
-
ReCAPSE: Recurrence using Claims and PROs for SEER Enhancement
Huang, B. (PI), Adams, V. (CoI), Durbin, E. B. (CoI), Lei, F. (CoI) & Chen, J. (Former CoI)
7/1/22 → 12/31/24
Project: Research project
-
Enhancing Patient Navigation at University of Kentucky Markey Cancer Center
Mullett, T. (PI), Chih, M.-Y. (CoI) & Hull, P. (CoI)
7/1/22 → 12/31/24
Project: Research project
-
Comprehensive Connected Cancer Care (C4)
Mullett, T. (PI), Chih, M.-Y. (CoI), McLouth, L. (CoI), Shelton, B. (CoI), Hull, P. (CoPI) & Faiola, A. (Former CoI)
7/1/22 → 6/30/27
Project: Research project
-
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
Li, Z. (PI), Allison, D. (CoI), Liu, J. (CoI), Lutz, C. (CoI) & Wang, C. (Former CoI)
7/1/22 → 6/30/27
Project: Research project
-
Cancer Prevention and Control Programs for State Territorial and Tribal Organizations - NCCCP
Hull, P. (PI) & Knight, J. (CoI)
National Center for Chronic Disease Prevention & Healt
6/30/22 → 6/29/27
Project: Research project
-
Cancer Prevention and Control Programs for State Territorial and Tribal Organizations - NPCR
Durbin, E. B. (PI), Huang, B. (CoI) & Tucker, T. (CoI)
National Center for Chronic Disease Prevention & Healt
6/30/22 → 6/29/27
Project: Research project
-
A Phase 3, Randomized, Controlled, Multicenter, Open-Label Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Who Have Progressed Following One or Two Lines of Therapy
Myint, Z. (PI)
AVEO Pharmaceuticals Incorporated
5/25/22 → 10/30/25
Project: Research project
-
Combating Melanoma Resistance by Targeting ABL1/2
Plattner, R. (PI), Arays, R. (CoI), Gandhapudi, S. (CoI), Liu, J. (CoI), Richards, D. (CoI), Wang, C. (CoI), Yan, D. (CoI), Zhang, S. (CoI), Kolesar, J. (CoPI), COHEN, D. (Former CoI) & Wang, P. (Former CoI)
5/23/22 → 4/30/27
Project: Research project
-
22-LUN-127-AZ: A Phase III, Double-blind, Randomised, Placebo-Controlled, International Study to Assess the Efficacy and Safety of Adjuvant Osimertinib Versus Placebo in Participants With EGFR Mutation-positive Stage IA2-IA3 Non-small Cell Lung Cancer, Fo
Villano, PhD, J. (PI) & Zinner, R. (Former PI)
AstraZeneca Pharmaceuticals LP (domestic)
5/12/22 → 2/6/25
Project: Research project
-
A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination with Pembrolizumab in Participants with Locally Advanced or Metastatic Solid Tumors
Villano, PhD, J. (PI) & Chauhan, A. (Former PI)
Astellas Pharma Global Development Incorporated
4/8/22 → 1/30/26
Project: Research project
-
A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome.
Anthony, L. (PI) & Chauhan, A. (Former PI)
4/6/22 → 3/8/25
Project: Research project
-
A multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab Relative to Apixaban on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients with Cancer Associated VTE
Villano, PhD, J. (PI)
Anthos Therapeutics Incorporated
3/23/22 → 2/14/25
Project: Research project
-
A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (CAAA601A22301)
Anthony, L. (PI) & Chauhan, A. (Former PI)
Advanced Accelerator Applications SA
1/7/22 → 11/2/25
Project: Research project
-
Phase 3 Randomized Trial of DFP-10917 vs Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High & Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Pat
Qasrawi, A. (PI) & Hildebrandt, G. (Former PI)
12/23/21 → 8/21/25
Project: Research project
-
Phase II Clinical Trial Evaluating Cabozantinib and Pembrolizumab in Second-Line Therapy for Metastatic Pancreatic Adenocarcinoma
Kim, J. (PI), Fan, W.-M. (CoI), Gao, M. (CoI), Higashi, R. (CoI), Rueckert, J. (CoI) & Qasem, S. (Former CoI)
12/15/21 → 6/7/25
Project: Research project
-
A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination with AMG 404 in Subjects with Small Cell Lung Cancer (SCLC)
Hao, Z. (PI) & Chauhan, A. (Former PI)
10/4/21 → 8/29/25
Project: Research project
-
Scope - Subject Injury: A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination with AMG 404 in Subjects with Small Cell Lung Cancer (SCLC)
Hao, Z. (PI) & Chauhan, A. (Former PI)
10/4/21 → 8/29/25
Project: Research project
-
A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV)
Villano, PhD, J. (PI)
CNS Pharmaceuticals Incorporated
9/29/21 → 7/18/25
Project: Research project
-
Gold-derived Therapeutic Compounds for Disease Application
Awuah, S. (PI), O'Connor, K. (CoI) & Weiss, H. (CoI)
8/4/21 → 7/31/26
Project: Research project
-
Supplement: GMaP Supplement: University of Kentucky Markey Cancer Center - Cancer Support Grant
Evers, B. M. (PI), Cromo, M. (CoI) & Dignan, M. (CoI)
7/1/21 → 6/30/25
Project: Research project
-
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Myint, Z. (PI) & Wang, P. (Former PI)
6/14/21 → 6/12/25
Project: Research project
-
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1
Villano, PhD, J. (PI)
Pharmaceutical Research Associates
5/27/21 → 6/7/25
Project: Research project
-
Phase II Clinical Trial Evaluating Cabozantinib and Pembrolizumab in Metastatic Pancreatic Cancer
Kim, J. (PI)
4/29/21 → 6/7/25
Project: Research project
-
Expanded Access Protocol (EAP) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming For Commercial Release
Iragavarapu, C. (PI)
4/6/21 → 3/15/25
Project: Research project
-
Understanding Mechanisms and Consequences of T Cell Co-Receptor Regulated RNA Maturation
Lane, A. (PI), Fan, W.-M. (CoI) & Higashi, R. (CoI)
4/5/21 → 3/31/25
Project: Research project
-
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
Zhou, B. (PI), Lane, A. (CoI), St Clair, D. (CoI), Wang, C. (CoI) & Zhu, H. (Former CoI)
4/1/21 → 3/31/26
Project: Research project
-
Effectiveness and Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural, Underserved Patients
Mullett, T. (PI)
4/1/21 → 3/31/26
Project: Research project
-
Targeting Lipid Metabolism in Colorectal Cancer
Zaytseva, Y. (PI), Evers, B. M. (CoI), Lee, E. (CoI), Moseley, H. (CoI), Nikolova-Karakashian, M. (CoI), Rychahou, P. (CoI) & Weiss, H. (CoI)
4/1/21 → 3/31/26
Project: Research project
-
Improving Uptake of Cervical Cancer Prevention Services - Diversity Supplement Canedo
Dignan, M. (PI) & Canedo, J. (CoI)
4/1/21 → 3/31/25
Project: Research project
-
The Role of Crypt Fissioning in IBD Ulcer Healing
Barrett, T. (PI), Beyer, R. (CoI), Chaiswing, L. (CoI), Flomenhoft, D. (CoI), Gao, T. (CoI), Goretsky, T. (CoI), Harrison, D. (CoI), Kapur, N. (CoI), Lohr, K. (CoI), Sullivan, P. (CoI), Grigorian, A. (Former CoI), Holt, E. (Former CoI), Liu, J. (Former CoI) & Stromberg, A. (Former CoI)
National Institute Diabetes & Digestive & Kidney
2/24/21 → 1/31/25
Project: Research project
-
Modulation of Asparagine Bioavailability and Stress Response Signaling to Enhance T Cell Robustness and Maximize Immunotherapy
Fan, W.-M. (PI)
Research Institute at Nationwide Childrens Hospital
2/15/21 → 1/31/25
Project: Research project
-
HPV16 E6 Antibody Detection as an Early Marker for Oropharyngeal Cancer Among Men Living with HIV
Kuhs, K. (PI), Chen, L. (CoI), Fanucchi, L. (CoI) & Yeoh, M. (CoI)
National Institute of Dental and Craniofacial Research
2/5/21 → 4/30/26
Project: Research project
-
Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release
Iragavarapu, C. (PI) & Hildebrandt, G. (Former PI)
1/29/21 → 9/18/25
Project: Research project
-
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation
Arnold, S. (PI) & Zinner, R. (Former PI)
Mirati Therapeutics Incorporated
11/20/20 → 8/16/25
Project: Research project
-
A Phase II, Open-Label, Multi-Center Study of PDS0101 (ImmunoMAPK -RDOTAP/HPV-16 E6 & E7 Peptides) and Pembrolizumab (KEYTRUDA) Combination Immunotherapy as a First Line Treatment in Subjects with Recurrent
Arnold, S. (PI), Kejner, A. (Former PI) & Zinner, R. (Former PI)
11/2/20 → 7/26/25
Project: Research project
-
T-DXd vs. T-DM1 in high risk HER2-positive patients with residual invasive breast cancer following neoadjuvant therapy (DESTINY-Breast05)
Chambers, M. (PI)
11/1/20 → 12/3/25
Project: Research project
-
Mechanisms of UV-Mediated Melanoma Development
D'Orazio, J. (PI)
9/4/20 → 5/31/25
Project: Research project
-
IIBR Informatics: Comprehensive Metabolism Phenotype Characterization and Interpretation
Moseley, H. (PI) & Flight, R. (CoI)
8/15/20 → 7/31/25
Project: Research project